CHAPEL HILL, N.C., June 13 /PRNewswire/ -- Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value. Leading companies are integrating commercial insights earlier and earlier into the new product process in an effort to identify and target promising compounds, reduce development cycle time, focus resources for greatest impact and increase their potential for launching a blockbuster drug.
Early-Stage Commercialization activities range from therapeutic opportunity and competitive landscape assessments to thought-leader focus groups, initial pricing studies, and pre-efficacy forecasts during pre-clinical and Phases I and II development. Global pharmaceutical companies must find ways to improve early-stage decision making and enhance product design using commercial insights to gain an overall competitive advantage in the marketplace. With these issues top of mind, Best Practices, LLC conducted primary benchmark research newly published in the report, "Best Practices in New Product Commercialization."
In a benchmarking study that included such influential companies as Abbott, Allergan, Amgen, AstraZeneca, Bayer, Eli Lilly, Genentech, GSK, Merck and Novartis, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.
For a complimentary summary of the full report "Best Practices in New
Product Commercialization," click on the following link
Key topic areas in the research include:
-- Early Commercialization Structure
-- Functional Involvement in Commercialization Activities
-- Cross-Functional & Regional Collaboration
-- Essential Employee Skills & Experience
-- Investment Decision Leaders
-- Value of Early Commercialization
-- Product Commercialization Success Factors
Among the key metrics gathered in this report are:
-- Commercialization Function Oversight
-- Organizational Structure
-- Commercialization Relationship with Global Marketing
-- Commercialization Leadership Levels
-- Commercialization Functional Structure
-- Commercialization Function Resources (FTEs)
-- Commercialization Functional Responsibilities
-- Commercialization Launch Responsibilities
-- Commercialization Key Stakeholders
-- Commercialization Communication
-- Product Portfolio Decision Committee Composition
-- Investment Decision Drivers
For more information on this report, contact Robert Naylor at email@example.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/rr958.htm .
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved